Eventide Asset Management, LLC - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
12:15 pm
Unchanged
2023-12-3113GFreeline Therapeutics Holdings plc
FRLN
Eventide Asset Management, LLC0
0.000%
0
(Unchanged)
Filing
History
2024-02-14
12:04 pm
Purchase
2023-12-3113GCollegium Pharmaceutical, Inc.
COLL
Eventide Asset Management, LLC2,630,478
8.070%
885increase
(+0.03%)
Filing
History
2024-02-14
12:02 pm
Sale
2023-12-3113G908 Devices Inc.
MASS
Eventide Asset Management, LLC1,430,995
4.420%
-799,670decrease
(-35.85%)
Filing
History
2024-02-14
11:59 am
Purchase
2023-12-3113GKorro Bio, Inc.
KRRO
Eventide Asset Management, LLC546,325
6.830%
546,325increase
(New Position)
Filing
History
2024-02-14
11:54 am
Purchase
2023-12-3113GInozyme Pharma, Inc.
INZY
Eventide Asset Management, LLC3,179,837
5.150%
3,179,837increase
(New Position)
Filing
History
2024-02-14
11:48 am
Purchase
2023-12-3113GCelldex Therapeutics, Inc.
CLDX
Eventide Asset Management, LLC3,630,013
6.640%
3,630,013increase
(New Position)
Filing
History
2023-12-11
5:15 pm
Purchase
2023-11-3013GZentalis Pharmaceuticals, Inc.
ZNTL
Eventide Asset Management, LLC11,559,975
16.340%
3,745,936increase
(+47.94%)
Filing
History
2023-12-11
5:14 pm
Purchase
2023-11-3013GAura Biosciences, Inc.
AURA
Eventide Asset Management, LLC5,802,682
11.820%
3,551,314increase
(+157.74%)
Filing
History
2023-12-11
5:13 pm
Purchase
2023-11-3013GLexeo Therapeutics, Inc. Common Stock
LXEO
Eventide Asset Management, LLC3,002,831
11.930%
3,002,831increase
(New Position)
Filing
History
2023-11-13
4:10 pm
Purchase
2023-11-0113GVYNE Therapeutics Inc.
VYNE
Eventide Asset Management, LLC1,394,336
9.990%
1,394,336increase
(New Position)
Filing
History
2023-11-13
2:43 pm
Purchase
2023-10-3113GXometry, Inc.
XMTR
Eventide Asset Management, LLC5,730,339
12.650%
5,730,339increase
(New Position)
Filing
History
2023-10-10
3:40 pm
Purchase
2023-09-3013GZentalis Pharmaceuticals, Inc.
ZNTL
Eventide Asset Management, LLC7,814,039
11.070%
7,814,039increase
(New Position)
Filing
History
2023-02-14
3:04 pm
Unchanged
2022-12-3113GVital Farms, Inc.
VITL
Eventide Asset Management, LLC0
0.000%
0
(Unchanged)
Filing
History
2023-02-14
3:00 pm
Sale
2022-12-3113GSutro Biopharma, Inc.
STRO
Eventide Asset Management, LLC0
0.000%
-270,898decrease
(Position Closed)
Filing
History
2023-02-14
2:50 pm
Sale
2022-12-3113GESSA Pharma Inc.
EPIX
Eventide Asset Management, LLC0
0.000%
-3,318,647decrease
(Position Closed)
Filing
History
2023-02-14
2:37 pm
Unchanged
2022-12-3113GZymeworks Inc.
ZYME
Eventide Asset Management, LLC0
0.000%
0
(Unchanged)
Filing
History
2023-02-14
2:06 pm
Purchase
2022-12-3113GVectivBio Holding AG
VECT
Eventide Asset Management, LLC3,405,644
5.400%
1,066,600increase
(+45.60%)
Filing
History
2023-02-14
1:58 pm
Sale
2022-12-3113GPrometheus Biosciences, Inc.
RXDX
Eventide Asset Management, LLC1,032,938
2.200%
-2,709,569decrease
(-72.40%)
Filing
History
2023-02-14
1:54 pm
Purchase
2022-12-3113GFreeline Therapeutics Holdings plc
FRLN
Eventide Asset Management, LLC394,718
9.100%
162,341increase
(+69.86%)
Filing
History
2023-02-14
1:48 pm
Sale
2022-12-3113GCogent Biosciences, Inc.
COGT
Eventide Asset Management, LLC2,589,778
3.700%
-925,131decrease
(-26.32%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, Next